Header Logo

Connection

DAVID LONARD to Recurrence

Back to Details
This is a "connection" page, showing publications DAVID LONARD has written about Recurrence.
DAVID LONARD
Connection Strength
0.034
Recurrence
  1. Targeting NSD2-mediated SRC-3 liquid-liquid phase separation sensitizes bortezomib treatment in multiple myeloma. Nat Commun. 2021 02 15; 12(1):1022.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.